Search Ontology:
ChEBI
XJB-5-131
- Term ID
- CHEBI:173099
- Synonyms
-
- (4-{[(2S)-2-{[(2S)-2-({[(2S)-1-{(2S,3E,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-7-methyloct-3-enoyl}pyrrolidin-2-yl]carbonyl}amino)-3-methylbutanoyl]amino}-5-{[(benzyloxy)carbonyl]amino}pentanoyl]amino}-2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl
- XJB-5 131
- XJB-5131
- {4-[(1-{(2S,3E,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-7-methyloct-3-enoyl}-L-prolyl-L-valyl-N(5)-[(benzyloxy)carbonyl]-L-ornithyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl}oxidanyl
- Definition
- A peptidomimetic that is an inhibitor of ferroptosis and prevents the onset of motor decline in a mouse model for Huntington's disease.
- References
-
- cas:866404-31-1
- chemspider:9868412
- pubmed:17245186
- pubmed:17601494
- pubmed:17713394
- pubmed:20418384
- pubmed:22323894
- pubmed:23122961
- pubmed:23389888
- pubmed:23927692
- pubmed:23933481
- pubmed:25451170
- pubmed:26247199
- pubmed:26415224
- pubmed:26908614
- pubmed:27604998
- pubmed:27725964
- pubmed:28064218
- pubmed:29630611
- pubmed:29747066
- pubmed:30445591
- pubmed:31433458
- pubmed:32796819
- pubmed:33119220
- wikipedia.en:XJB-5-131
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from XJB-5-131
Phenotype where environments contain XJB-5-131
Phenotype modified by environments containing XJB-5-131
Phenotype affecting XJB-5-131
Human Disease Model